1. Turkey Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 67
Price: Single User License – US$2500
Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Summary
Global Markets Direct’s new report, ”Turkey Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018”, provides key market data on the Turkey Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Turkey Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Eli Lilly and Company, Novo
Nordisk A/S, LifeScan, Inc., Bayer HealthCare AG and others.
Reasons to buy

2. - Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Turkey Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/195378-turkey-diabetes-care-devices-investment-opportunities-analysis-
and-forecasts-to-2018.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Turkey 8
3.1 Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Turkey, Company Share (2010-2011) 14
4 Glucose Monitoring In Turkey 16
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 16
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 20
4.2 Glucose Monitoring Overall Volume (2004-2018) 22
4.2.1 Blood Glucose Meters, Volume (2004-2018) 26
4.3 Glucose Monitoring Average Price (2004-2018) 28
4.4 Glucose Monitoring Distribution Share (2010-2011) 29
4.5 Glucose Monitoring, Turkey, Company Share (2010-2011) 30
5 Insulin Delivery In Turkey 32
5.1 Insulin Delivery Overall Revenue, (2004-2018) 32
5.1.1 Insulin Pens, Revenue (2004-2018) 36
5.1.2 Insulin Pumps, Revenue (2004-2018) 40
5.2 Insulin Delivery Overall Volume (2004-2018) 43
5.2.1 Insulin Pens, Volume (2004-2018) 47
5.2.2 Insulin Pumps, Volume (2004-2018) 51
5.3 Insulin Delivery Average Price (2004-2018) 53
5.4 Insulin Delivery Distribution Share (2010-2011) 54
5.5 Insulin Delivery, Turkey, Company Share (2010-2011) 55

3. 6 Overview of Key Companies in Turkey Diabetes Care Devices Market 56
6.1 F. Hoffmann-La Roche Ltd. 56
6.1.1 Company Overview 56
6.2 Sanofi 56
6.2.1 Company Overview 56
6.3 Eli Lilly and Company 57
6.3.1 Company Overview 57
6.4 Novo Nordisk A/S 57
6.4.1 Company Overview 57
6.5 LifeScan, Inc. 58
6.5.1 Company Overview 58
6.6 Bayer HealthCare AG 58
6.6.1 Company Overview 58
6.7 Becton, Dickinson and Company 58
6.7.1 Company Overview 58
6.8 Abbott Laboratories 59
6.8.1 Company Overview 59
6.9 Medtronic, Inc. 59
6.9.1 Company Overview 59
6.10 Terumo Corporation 60
6.10.1 Company Overview 60
6.11 Nipro Corporation 60
6.11.1 Company Overview 60
6.12 Terumo Corporation 61
6.12.1 Company Overview 61
7 Appendix 62
7.1 Global Markets Direct Research Methodology 62
7.2 Definitions of Markets Covered in the Report 63
7.2.1 Diabetes Care Devices 63
7.3 Secondary Research 65
7.4 Primary Research 65
7.5 Models 66
7.6 Forecasts 66
7.7 Expert Panel Validation 66
7.8 Currency Conversion 67
7.9 Contact Us 67
7.10 Disclaimer 67
1.1 List of Tables
Table 1: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, 2004-2018 9
Table 2: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 11

4. Table 3: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 13
Table 4: Diabetes Care Devices, Turkey, Company Share by Revenue ($m), USD Constant, 2010-
2011 15
Table 5: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 17
Table 6: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 19
Table 7: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USD
Constant, Historic, 2004-2011 20
Table 8: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USD
Constant, Forecast, 2011-2018 21
Table 9: Glucose Monitoring, Turkey, Volume (Units) by Segment, Historic, 2004-2011 23
Table 10: Glucose Monitoring, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 25
Table 11: Blood Glucose Meters, Turkey, Volume (Units), Historic, 2004-2011 26
Table 12: Blood Glucose Meters, Turkey, Volume (Units), Forecast, 2011-2018 27
Table 13: Glucose Monitoring, Turkey, Average Price ($), Historic, 2004-2011 28
Table 14: Glucose Monitoring, Turkey, Average Price ($), Forecast, 2011-2018 28
Table 15: Glucose Monitoring, Turkey, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 29
Table 16: Glucose Monitoring, Turkey, Company Share by Revenue ($m), USD Constant, 2010-
2011 31
Table 17: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
33
Table 18: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 35
Table 19: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 37
Table 20: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 39
Table 21: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,
Historic, 2004-2011 41
Table 22: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,
Forecast, 2011-2018 42
Table 23: Insulin Delivery, Turkey, Volume (Units) by Segment, Historic, 2004-2011 44
Table 24: Insulin Delivery, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 46
Table 25: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Historic, 2004-2011 48
Table 26: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50
Table 27: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Historic, 2004-2011
51
Table 28: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Forecast, 2011-2018
52

5. Table 29: Insulin Delivery, Turkey, Average Price ($), Historic, 2004-2011 53
Table 30: Insulin Delivery, Turkey, Average Price ($), Forecast, 2011-2018 53
Table 31: Insulin Delivery, Turkey, Distribution Share by Revenue ($m), USD Constant, 2010-2011
54
Table 32: Insulin Delivery, Turkey, Company Share by Revenue ($m), USD Constant, 2010-2011
55
1.2 List of Figures
Figure 1: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 10
Figure 3: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 12
Figure 4: Diabetes Care Devices, Turkey, Company Share (%), 2011 14
Figure 5: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 16
Figure 6: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 18
Figure 7: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USD
Constant, Historic, 2004-2011 20
Figure 8: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USD
Constant, Forecast, 2011-2018 21
Figure 9: Glucose Monitoring, Turkey, Volume (Units) by Segment, Historic, 2004-2011 22
Figure 10: Glucose Monitoring, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 24
Figure 11: Blood Glucose Meters, Turkey, Volume (Units), Historic, 2004-2011 26
Figure 12: Blood Glucose Meters, Turkey, Volume (Units), Forecast, 2011-2018 27
Figure 13: Glucose Monitoring, Turkey, Company Share (%), 2011 30
Figure 14: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 32
Figure 15: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 34
Figure 16: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 36
Figure 17: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 38
Figure 18: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,
Historic, 2004-2011 40
Figure 19: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,
Forecast, 2011-2018 42
Figure 20: Insulin Delivery, Turkey, Volume (Units) by Segment, Historic, 2004-2011 43
Figure 21: Insulin Delivery, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 45
Figure 22: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Historic, 2004-2011 47

6. Figure 23: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49
Figure 24: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Historic, 2004-2011
51
Figure 25: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Forecast, 2011-
2018 52
Figure 26: Insulin Delivery, Turkey, Company Share (%), 2011 55
Figure 27: Global Markets Direct Methodology 62
Contact: sales@reportsandreports.com for more information.